Managing patients after myocardial infarction.
Thrombolytic therapy clearly saves lives when administered in the first critical hours after acute MI. Consequently, most patients can now be treated initially at the community hospital level. Transfer to a tertiary center may be reserved for those who become symptomatic after thrombolysis, which, of course, is not a panacea. Reducing the risks of reinfarction and death remain major issues.
Cohen
L S
LS
Yale University.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D001241:Aspirin / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D006334:Heart Function Tests; D006801:Humans; D009203:Myocardial Infarction / Q000534:rehabilitation / Q000628:therapy*; D013300:Streptokinase / Q000008:administration & dosage / Q000627:therapeutic use; D015912:Thrombolytic Therapy; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D013300:Streptokinase; D010959:Tissue Plasminogen Activator; D001241:Aspirin